|Articles|August 1, 2011
- BioPharm International-08-01-2011
- Volume 24
- Issue 8
BioPharm International, August 2011 Issue (PDF)
Top 1000 Biomanufacturing Facilities
Advertisement
Articles in this issue
about 14 years ago
Efficient Multiproduct Process Development Case Studyabout 14 years ago
Offshoring Biomanufacturingabout 14 years ago
Particulate Quality of Single-Use Filling Systemsabout 14 years ago
Developing an International Dialogue on Biologics Standardsabout 14 years ago
FDA Maps Strategy to Counter Supply-Chain Threatsabout 14 years ago
Biopharmaceutical High Performanceabout 14 years ago
Biosimilars or Bustabout 14 years ago
Top 1000 Global Biomanufacturing FacilitiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
